sta 409 Search Results


sta 409c/cd apparatus  (NETZSCH)
90
NETZSCH sta 409c/cd apparatus
Sta 409c/Cd Apparatus, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sta 409c/cd apparatus/product/NETZSCH
Average 90 stars, based on 1 article reviews
sta 409c/cd apparatus - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
409 ep instrument  (NETZSCH)
90
NETZSCH 409 ep instrument
409 Ep Instrument, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/409 ep instrument/product/NETZSCH
Average 90 stars, based on 1 article reviews
409 ep instrument - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sta-409ep apparatus  (TA Instruments)
90
TA Instruments sta-409ep apparatus
Sta 409ep Apparatus, supplied by TA Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sta-409ep apparatus/product/TA Instruments
Average 90 stars, based on 1 article reviews
sta-409ep apparatus - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sta-ms 409 pc luxx  (NETZSCH)
90
NETZSCH sta-ms 409 pc luxx
Sta Ms 409 Pc Luxx, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sta-ms 409 pc luxx/product/NETZSCH
Average 90 stars, based on 1 article reviews
sta-ms 409 pc luxx - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
luxx 409 pg analyser  (NETZSCH)
90
NETZSCH luxx 409 pg analyser
Luxx 409 Pg Analyser, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luxx 409 pg analyser/product/NETZSCH
Average 90 stars, based on 1 article reviews
luxx 409 pg analyser - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sta 409 pc luxx instrument  (NETZSCH)
90
NETZSCH sta 409 pc luxx instrument
Sta 409 Pc Luxx Instrument, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sta 409 pc luxx instrument/product/NETZSCH
Average 90 stars, based on 1 article reviews
sta 409 pc luxx instrument - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
netsch sta 409-pc luxx  (Burlington Industries)
90
Burlington Industries netsch sta 409-pc luxx
Netsch Sta 409 Pc Luxx, supplied by Burlington Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/netsch sta 409-pc luxx/product/Burlington Industries
Average 90 stars, based on 1 article reviews
netsch sta 409-pc luxx - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
409-pc sta apparatus  (NETZSCH)
90
NETZSCH 409-pc sta apparatus
409 Pc Sta Apparatus, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/409-pc sta apparatus/product/NETZSCH
Average 90 stars, based on 1 article reviews
409-pc sta apparatus - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
ran activation assay sta-409  (Cell Biolabs Inc)
90
Cell Biolabs Inc ran activation assay sta-409
a Western blot analysis of HDAC8 in 32D-CM cells with NS or Hdac8 shRNA (#1, #2) (left). Relative expression of pre-miR-126 and mature miR-126 in 32D-CM cells with NS (red) vs. Hdac8 shRNA#1 (light blue), Hdac8 shRNA#2 (dark blue) (right). b Relative expression in 32D-CM cells treated with vehicle (red) vs. HDAC8i (22d 2.5 μM or 5 μM; purple) for pre-miR-126 (left; 2.5 μM p < 0.0001; 5 μM p < 0.0001) and miR-126 (right; 2.5 μM p = 0.012; 5 μM p = 0.0055). c Representative image of IF co-staining of <t>RAN</t> (green) and HDAC8 (red) in 32D cells (left; scale bar 10 μm). IP with anti-IgG control or anti-HDAC8 followed by immunoblotting (IB) with anti-RAN antibodies (right). Representative results of two independent experiments with similar results are shown. d IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN in 32D-CM cells not-treated (NT) or treated with DMSO vehicle or 22d (2 µM) (left). The levels of RAN-GTP determined by <t>RAN</t> <t>activation</t> assay (right). The densitometry of RAN-GTP levels measured from three assays are shown on the bottom. e IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) in 32D-CM cells not-treated (NT) or transduced with shCtrl control or shCM for 24 h. f IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) of BM cells isolated from Ctrl or CM mice. g Schematic model of the mechanism by which CM regulates miR-126/EGFL7 transcription as well as miR-126 biogenesis through enhancing HDAC8 activity which in turn promotes RAN-XPO5 mediated transportation. Pre-miR-126 was normalized to B2m and mature miR-126 was normalized to snoRNA234 . Data are presented as the mean ± SD and statistical significance shown was determined using two-tailed Student’s T tests (* p < 0.05; ** p < 0.01; *** p < 0.001).
Ran Activation Assay Sta 409, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ran activation assay sta-409/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
ran activation assay sta-409 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
tga/sta 409pc apparatus  (METTLER TOLEDO)
90
METTLER TOLEDO tga/sta 409pc apparatus
a Western blot analysis of HDAC8 in 32D-CM cells with NS or Hdac8 shRNA (#1, #2) (left). Relative expression of pre-miR-126 and mature miR-126 in 32D-CM cells with NS (red) vs. Hdac8 shRNA#1 (light blue), Hdac8 shRNA#2 (dark blue) (right). b Relative expression in 32D-CM cells treated with vehicle (red) vs. HDAC8i (22d 2.5 μM or 5 μM; purple) for pre-miR-126 (left; 2.5 μM p < 0.0001; 5 μM p < 0.0001) and miR-126 (right; 2.5 μM p = 0.012; 5 μM p = 0.0055). c Representative image of IF co-staining of <t>RAN</t> (green) and HDAC8 (red) in 32D cells (left; scale bar 10 μm). IP with anti-IgG control or anti-HDAC8 followed by immunoblotting (IB) with anti-RAN antibodies (right). Representative results of two independent experiments with similar results are shown. d IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN in 32D-CM cells not-treated (NT) or treated with DMSO vehicle or 22d (2 µM) (left). The levels of RAN-GTP determined by <t>RAN</t> <t>activation</t> assay (right). The densitometry of RAN-GTP levels measured from three assays are shown on the bottom. e IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) in 32D-CM cells not-treated (NT) or transduced with shCtrl control or shCM for 24 h. f IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) of BM cells isolated from Ctrl or CM mice. g Schematic model of the mechanism by which CM regulates miR-126/EGFL7 transcription as well as miR-126 biogenesis through enhancing HDAC8 activity which in turn promotes RAN-XPO5 mediated transportation. Pre-miR-126 was normalized to B2m and mature miR-126 was normalized to snoRNA234 . Data are presented as the mean ± SD and statistical significance shown was determined using two-tailed Student’s T tests (* p < 0.05; ** p < 0.01; *** p < 0.001).
Tga/Sta 409pc Apparatus, supplied by METTLER TOLEDO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tga/sta 409pc apparatus/product/METTLER TOLEDO
Average 90 stars, based on 1 article reviews
tga/sta 409pc apparatus - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
thermobalance netsch sta 409  (Pfeiffer Vacuum)
90
Pfeiffer Vacuum thermobalance netsch sta 409
a Western blot analysis of HDAC8 in 32D-CM cells with NS or Hdac8 shRNA (#1, #2) (left). Relative expression of pre-miR-126 and mature miR-126 in 32D-CM cells with NS (red) vs. Hdac8 shRNA#1 (light blue), Hdac8 shRNA#2 (dark blue) (right). b Relative expression in 32D-CM cells treated with vehicle (red) vs. HDAC8i (22d 2.5 μM or 5 μM; purple) for pre-miR-126 (left; 2.5 μM p < 0.0001; 5 μM p < 0.0001) and miR-126 (right; 2.5 μM p = 0.012; 5 μM p = 0.0055). c Representative image of IF co-staining of <t>RAN</t> (green) and HDAC8 (red) in 32D cells (left; scale bar 10 μm). IP with anti-IgG control or anti-HDAC8 followed by immunoblotting (IB) with anti-RAN antibodies (right). Representative results of two independent experiments with similar results are shown. d IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN in 32D-CM cells not-treated (NT) or treated with DMSO vehicle or 22d (2 µM) (left). The levels of RAN-GTP determined by <t>RAN</t> <t>activation</t> assay (right). The densitometry of RAN-GTP levels measured from three assays are shown on the bottom. e IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) in 32D-CM cells not-treated (NT) or transduced with shCtrl control or shCM for 24 h. f IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) of BM cells isolated from Ctrl or CM mice. g Schematic model of the mechanism by which CM regulates miR-126/EGFL7 transcription as well as miR-126 biogenesis through enhancing HDAC8 activity which in turn promotes RAN-XPO5 mediated transportation. Pre-miR-126 was normalized to B2m and mature miR-126 was normalized to snoRNA234 . Data are presented as the mean ± SD and statistical significance shown was determined using two-tailed Student’s T tests (* p < 0.05; ** p < 0.01; *** p < 0.001).
Thermobalance Netsch Sta 409, supplied by Pfeiffer Vacuum, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thermobalance netsch sta 409/product/Pfeiffer Vacuum
Average 90 stars, based on 1 article reviews
thermobalance netsch sta 409 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sta jupiter 409 pl luxx  (NETZSCH)
90
NETZSCH sta jupiter 409 pl luxx
a Western blot analysis of HDAC8 in 32D-CM cells with NS or Hdac8 shRNA (#1, #2) (left). Relative expression of pre-miR-126 and mature miR-126 in 32D-CM cells with NS (red) vs. Hdac8 shRNA#1 (light blue), Hdac8 shRNA#2 (dark blue) (right). b Relative expression in 32D-CM cells treated with vehicle (red) vs. HDAC8i (22d 2.5 μM or 5 μM; purple) for pre-miR-126 (left; 2.5 μM p < 0.0001; 5 μM p < 0.0001) and miR-126 (right; 2.5 μM p = 0.012; 5 μM p = 0.0055). c Representative image of IF co-staining of <t>RAN</t> (green) and HDAC8 (red) in 32D cells (left; scale bar 10 μm). IP with anti-IgG control or anti-HDAC8 followed by immunoblotting (IB) with anti-RAN antibodies (right). Representative results of two independent experiments with similar results are shown. d IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN in 32D-CM cells not-treated (NT) or treated with DMSO vehicle or 22d (2 µM) (left). The levels of RAN-GTP determined by <t>RAN</t> <t>activation</t> assay (right). The densitometry of RAN-GTP levels measured from three assays are shown on the bottom. e IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) in 32D-CM cells not-treated (NT) or transduced with shCtrl control or shCM for 24 h. f IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) of BM cells isolated from Ctrl or CM mice. g Schematic model of the mechanism by which CM regulates miR-126/EGFL7 transcription as well as miR-126 biogenesis through enhancing HDAC8 activity which in turn promotes RAN-XPO5 mediated transportation. Pre-miR-126 was normalized to B2m and mature miR-126 was normalized to snoRNA234 . Data are presented as the mean ± SD and statistical significance shown was determined using two-tailed Student’s T tests (* p < 0.05; ** p < 0.01; *** p < 0.001).
Sta Jupiter 409 Pl Luxx, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sta jupiter 409 pl luxx/product/NETZSCH
Average 90 stars, based on 1 article reviews
sta jupiter 409 pl luxx - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


a Western blot analysis of HDAC8 in 32D-CM cells with NS or Hdac8 shRNA (#1, #2) (left). Relative expression of pre-miR-126 and mature miR-126 in 32D-CM cells with NS (red) vs. Hdac8 shRNA#1 (light blue), Hdac8 shRNA#2 (dark blue) (right). b Relative expression in 32D-CM cells treated with vehicle (red) vs. HDAC8i (22d 2.5 μM or 5 μM; purple) for pre-miR-126 (left; 2.5 μM p < 0.0001; 5 μM p < 0.0001) and miR-126 (right; 2.5 μM p = 0.012; 5 μM p = 0.0055). c Representative image of IF co-staining of RAN (green) and HDAC8 (red) in 32D cells (left; scale bar 10 μm). IP with anti-IgG control or anti-HDAC8 followed by immunoblotting (IB) with anti-RAN antibodies (right). Representative results of two independent experiments with similar results are shown. d IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN in 32D-CM cells not-treated (NT) or treated with DMSO vehicle or 22d (2 µM) (left). The levels of RAN-GTP determined by RAN activation assay (right). The densitometry of RAN-GTP levels measured from three assays are shown on the bottom. e IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) in 32D-CM cells not-treated (NT) or transduced with shCtrl control or shCM for 24 h. f IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) of BM cells isolated from Ctrl or CM mice. g Schematic model of the mechanism by which CM regulates miR-126/EGFL7 transcription as well as miR-126 biogenesis through enhancing HDAC8 activity which in turn promotes RAN-XPO5 mediated transportation. Pre-miR-126 was normalized to B2m and mature miR-126 was normalized to snoRNA234 . Data are presented as the mean ± SD and statistical significance shown was determined using two-tailed Student’s T tests (* p < 0.05; ** p < 0.01; *** p < 0.001).

Journal: Nature Communications

Article Title: Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance

doi: 10.1038/s41467-021-26420-7

Figure Lengend Snippet: a Western blot analysis of HDAC8 in 32D-CM cells with NS or Hdac8 shRNA (#1, #2) (left). Relative expression of pre-miR-126 and mature miR-126 in 32D-CM cells with NS (red) vs. Hdac8 shRNA#1 (light blue), Hdac8 shRNA#2 (dark blue) (right). b Relative expression in 32D-CM cells treated with vehicle (red) vs. HDAC8i (22d 2.5 μM or 5 μM; purple) for pre-miR-126 (left; 2.5 μM p < 0.0001; 5 μM p < 0.0001) and miR-126 (right; 2.5 μM p = 0.012; 5 μM p = 0.0055). c Representative image of IF co-staining of RAN (green) and HDAC8 (red) in 32D cells (left; scale bar 10 μm). IP with anti-IgG control or anti-HDAC8 followed by immunoblotting (IB) with anti-RAN antibodies (right). Representative results of two independent experiments with similar results are shown. d IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN in 32D-CM cells not-treated (NT) or treated with DMSO vehicle or 22d (2 µM) (left). The levels of RAN-GTP determined by RAN activation assay (right). The densitometry of RAN-GTP levels measured from three assays are shown on the bottom. e IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) in 32D-CM cells not-treated (NT) or transduced with shCtrl control or shCM for 24 h. f IP with anti-RAN and IB with antibodies for Ac-Lys, RCC1, XPO5, or RAN (left), and RAN activation assay (right) of BM cells isolated from Ctrl or CM mice. g Schematic model of the mechanism by which CM regulates miR-126/EGFL7 transcription as well as miR-126 biogenesis through enhancing HDAC8 activity which in turn promotes RAN-XPO5 mediated transportation. Pre-miR-126 was normalized to B2m and mature miR-126 was normalized to snoRNA234 . Data are presented as the mean ± SD and statistical significance shown was determined using two-tailed Student’s T tests (* p < 0.05; ** p < 0.01; *** p < 0.001).

Article Snippet: RAN activation assay (Cell Biolabs, STA-409) was performed to measure activities of RAN according to the manufacturer’s guidance.

Techniques: Western Blot, shRNA, Expressing, Staining, Control, Activation Assay, Transduction, Isolation, Activity Assay, Two Tailed Test